Zeo ScientifiX OCEL Stock
Zeo ScientifiX Price Chart
Zeo ScientifiX OCEL Financial and Trading Overview
Zeo ScientifiX stock price | 2.75 USD |
Previous Close | 0.0099 USD |
Open | 0.0099 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.0089 - 0.01 USD |
52 Week Range | 0.005 - 0.05 USD |
Volume | 1.13M USD |
Avg. Volume | 646.64K USD |
Market Cap | 14.91M USD |
Beta (5Y Monthly) | 5.416197 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
OCEL Valuation Measures
Enterprise Value | 13.76M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 2.5002685 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 2.308 |
Enterprise Value/EBITDA | -1.545 |
Trading Information
Zeo ScientifiX Stock Price History
Beta (5Y Monthly) | 5.416197 |
52-Week Change | -33.33% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.05 USD |
52 Week Low | 0.005 USD |
50-Day Moving Average | 0.01 USD |
200-Day Moving Average | 0.02 USD |
OCEL Share Statistics
Avg. Volume (3 month) | 646.64K USD |
Avg. Daily Volume (10-Days) | 580.63K USD |
Shares Outstanding | 1.49B |
Float | 700.26M |
Short Ratio | N/A |
% Held by Insiders | 49.85% |
% Held by Institutions | 0.0020% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | October 31, 2022 |
Most Recent Quarter (mrq) | January 31, 2023 |
Next Fiscal Year End | October 31, 2023 |
Profitability
Profit Margin | -159.16% |
Operating Margin (ttm) | -157.29% |
Gross Margin | 88.11% |
EBITDA Margin | -149.33% |
Management Effectiveness
Return on Assets (ttm) | -183.24% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 5.96M USD |
Revenue Per Share (ttm) | 0.005 USD |
Quarterly Revenue Growth (yoy) | -33.10% |
Gross Profit (ttm) | 5.74M USD |
EBITDA | -8903695 USD |
Net Income Avi to Common (ttm) | -9489477 USD |
Diluted EPS (ttm) | -0.01 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 1.42M USD |
Total Cash Per Share (mrq) | 0.001 USD |
Total Debt (mrq) | 423.49K USD |
Total Debt/Equity (mrq) | 62.55 USD |
Current Ratio (mrq) | 0.774 |
Book Value Per Share (mrq) | 0 |
Cash Flow Statement
Operating Cash Flow (ttm) | -3888570 USD |
Levered Free Cash Flow (ttm) | -3337740 USD |
Profile of Zeo ScientifiX
Country | United States |
State | FL |
City | Miami |
Address | 1951 Northwest 7th Avenue |
ZIP | 33136 |
Phone | 888 963 7881 |
Website | https://www.organicell.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 20 |
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicines. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent, which is in Phase I/II clinical trial to treat COVID-19, COPD, and osteoarthritis. The company also provides independent education, advertising, and marketing services to medical and other healthcare, anti-aging, and regenerative service providers. It has a research and development agreement with the Centers for Disease Control and Prevention to determine the anti-inflammatory and anti-infective effectiveness of Zofin in experimental models of influenza infection; and an agreement with Oklahoma State University to evaluate Zofin for the treatment of respiratory diseases caused by virus infections of pandemic potential. The company was formerly known as Biotech Products Services and Research, Inc. and changed its name to Organicell Regenerative Medicine, Inc. in June 2018. Organicell Regenerative Medicine, Inc. was incorporated in 2011 and is headquartered in Miami, Florida.
Q&A For Zeo ScientifiX Stock
What is a current OCEL stock price?
Zeo ScientifiX OCEL stock price today per share is 2.75 USD.
How to purchase Zeo ScientifiX stock?
You can buy OCEL shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zeo ScientifiX?
The stock symbol or ticker of Zeo ScientifiX is OCEL.
Which industry does the Zeo ScientifiX company belong to?
The Zeo ScientifiX industry is Biotechnology.
How many shares does Zeo ScientifiX have in circulation?
The max supply of Zeo ScientifiX shares is 6.13M.
What is Zeo ScientifiX Price to Earnings Ratio (PE Ratio)?
Zeo ScientifiX PE Ratio is 0.00000000 now.
What was Zeo ScientifiX earnings per share over the trailing 12 months (TTM)?
Zeo ScientifiX EPS is 0 USD over the trailing 12 months.
Which sector does the Zeo ScientifiX company belong to?
The Zeo ScientifiX sector is Healthcare.